Zeitungsständer (Symbolbild).
Montag, 14.11.2022 07:32 von | Aufrufe: 911

AUXLY REPORTS Q3 2022 FINANCIAL RESULTS

Zeitungsständer (Symbolbild). © AdrianHancu / iStock Editorial / Getty Images Plus / Getty Images

PR Newswire

TORONTO, Nov. 14, 2022 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") today released its financial results for the three and nine months ended September 30, 2022. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares ("Shares") and per Share amounts.

Q3 2022 Highlights

  • Total net revenues from sale of adult use cannabis in Canada of $19.8 million for the three months ended September 30, 2022, a 19% decrease from the same period last year and a 28% increase year-to-date;
  • SG&A declined approximately 11% from the previous quarter as the Company continues to focus its efforts on reducing costs;
  • Adjusted EBITDA was negative $5.8 million, an improvement of $0.3 million as compared to the same period last year;
  • Auxly Leamington continues to contribute to positive gross margins through low-cost cultivation and increased yields;
  • Continues to rank among the top 10 LPs in Canada by total recreational retail sales as the Company continues to launch new and exciting cannabis products to the Canadian market.

Q3 Highlights

 

For the three months ended:

(000's)


ARIVA.DE Börsen-Geflüster

September 30, 2022

September 30, 2021

Change 

Change 

Total net revenues

$               19,830

$               24,493

$       (4,663)

-19 %

Net income/(loss)*

(60,102)

(13,527)

(46,575)

-344 %

Net income/(loss) from continuing operations*

(60,102)

(13,527)

(46,575)

-344 %

Adjusted EBITDA**

(5,776)

(6,099)

323

5 %

Weighted average shares outstanding

901,521,265

825,612,944

75,908,321

9 %






For the nine months ended:

(000's)

September 30, 2022

September 30, 2021

Change 

Change 

Total net revenues

$              69,791

$              54,511

$          15,280

28 %

Net income/(loss)*

(114,237)

(15,363)

(98,874)

-644 %

Net income/(loss) from continuing operations*

(114,237)

(27,519)

(86,718)

-315 %

Adjusted EBITDA**

(16,095)

(15,628)

(467)

-3 %

Weighted average shares outstanding

884,496,806

767,844,307

116,652,499

15 %






As at:

(000's)

September 30, 2022

December 31, 2021

Change 

Change 

Cash and equivalents

$              16,019

$              14,754

$            1,265

9 %

Total assets

$            345,060

$            450,422

$       (105,362)

-23 %

Debt***

$            173,689

$            168,809

$            4,880

3 %


*Attributable to shareholders of the Company
**Adjusted EBITDA is a Non-IFRS financial measure.  Refer to the Non-GAAP Measures 
*** Debt is a supplementary financial measure.  Refer to the Non-GAAP Measures 

 

Results of Operations

For the periods ended:

Three months September 30,

Nine months September 30,

(000's)

2022

2021

2022

Werbung

Mehr Nachrichten zum Fonds kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.